Oxford BioDynamics Plc
OBD.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | £4,041 | £4,041 | £10,042 | £18,834 |
| - Cash | £1,392 | £4,261 | £1,827 | £1,187 |
| + Debt | £5,111 | £5,140 | £5,740 | £6,005 |
| Enterprise Value | £7,760 | £4,920 | £13,955 | £23,652 |
| Revenue | £508 | £587 | £309 | £327 |
| % Growth | -13.5% | 90% | -5.5% | – |
| Gross Profit | -£3,072 | -£3,077 | -£3,316 | -£3,870 |
| % Margin | -604.7% | -524.2% | -1,073.1% | -1,183.5% |
| EBITDA | -£4,757 | -£5,044 | -£5,935 | -£4,030 |
| % Margin | -936.4% | -859.3% | -1,920.7% | -1,232.4% |
| Net Income | -£5,402 | -£5,751 | -£6,842 | -£4,725 |
| % Margin | -1,063.4% | -979.7% | -2,214.2% | -1,445% |
| EPS Diluted | -0.003 | -0.007 | -0.022 | -0.023 |
| % Growth | 58.8% | 68.9% | 6.4% | – |
| Operating Cash Flow | -£2,762 | -£4,947 | -£6,733 | -£3,554 |
| Capital Expenditures | -£17 | £0 | -£14 | -£292 |
| Free Cash Flow | -£2,779 | -£4,947 | -£6,747 | -£3,846 |